| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $35.6M | -0.5% |
| Cost of Revenue | $32.8M | +2.9% |
| Gross Profit | $2.8M | -28.4% |
| R&D Expense | $633K | -9.5% |
| SG&A Expense | $6.4M | -2.1% |
| Operating Income | -$5.9M | -55.8% |
| Pre-tax Income | -$6.0M | -57.1% |
| Income Tax | -$879K | — |
| Net Income | -$5.1M |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -25.6% |
| Accounts Receivable | $32.7M | +256.8% |
| Inventory | $136K | — |
| Current Assets | $42.0M | +124.5% |
| Total Assets | $48.8M | +159.5% |
| Current Liabilities | $35.1M | +420.2% |
| Total Liabilities | $35.2M | +420.6% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | +0.3% |
| Capital Expenditures | $4K | +994.4% |
| Investing Cash Flow | -$4K | -994.4% |
| Financing Cash Flow | $7.8M | +2733.0% |
| Free Cash Flow | -$8.2M | +0.3% |
| -36.1% |
| EPS (Basic) | -$0.09 | -28.6% |
| EPS (Diluted) | -$0.09 | -28.6% |
| Stockholders' Equity |
| $13.7M |
| +12.8% |